GENEVA — Technical experts at the World Health Organization
(
WHO) will review on April 26 Chinese drugmaker Sinopharm's COVID-19 vaccine
for possible emergency use listing, to be followed by the Sinovac jab on May 3,
the agency said on Thursday.
اضافة اعلان
"We would expect a decision a couple of days
later," the WHO said in response to a Reuters query.
So far COVID-19 vaccines made by Pfizer AstraZeneca and
Johnson & Johnson have received a WHO listing - an endorsement of their
safety and efficacy that helps to guide countries' regulatory agencies.
Read more
lifestyle